Company / Book Value per Share
Amneal Pharmaceuticals, Inc. Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.402
FY2025
5-year range
-$0.724 / $2.728
FY2021-FY2025
Trend
+44.5%
vs FY2024
Sector context
#193 of 209
Health Care
What the data says
Among 209 Health Care companies, Amneal Pharmaceuticals, Inc. is in the bottom 8% for book value per share. Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching -$0.402.
Based on SEC 10-K filings.
-$0.402 in FY2025.
Declined from $0.13 to -$0.402 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 209This company -$0.402 Sector average $189.406
▼
-100.2% below sector average
Key checks
Key Insights
- In FY2025, book value per share increased 44.5% year-over-year.
- Ranks #193 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2018.
- Lowest book value per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.402 | +44.5% |
| FY2024 | -$0.724 | -655.6% |
| FY2023 | $0.13 | -93.5% |
| FY2022 | $2.004 | -26.5% |
| FY2021 | $2.728 | +14.5% |
| FY2020 | $2.383 | +30.7% |
| FY2019 | $1.823 | -54.0% |
| FY2018 | $3.967 | - |
| FY2017 | $0 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026